Jennifer Brown, MD of Dana Farber, discusses the update of the 5 year data from the Ibrutinib study at the 58th ASH Annual Meeting in San Diego, CA.
The Ibrutinib Study: 5 Year Follow Up
Jennifer Brown, MD of Dana Farber, discusses the update of the 5 year data from the Ibrutinib study at the 58th ASH Annual Meeting in San Diego, CA.